INOVIS  EVENTS

PharmaCI USA

• Airport Mariott
  Newark, NJ USA
• 18-19 September 2019
• conference web site>
  

join INOVIS at more events +

INOVIS presents ...

DEVELOPING YOUR COMPETITIVE EXPERTISE: Late Life-Cycle Management & Competitive Uncertainty +

COMPETITIVE INTELLIGENCE "PRIME": Can Our Industry Keep Up?+

Dr. Baljit Singh
Managing Director & Partner, INOVIS
(formerly Director, Integrated Insights, Novartis)

with

Dr. Satish Kumar
Head, CI Strategies, Generics & Biosimilars, INOVIS
(formerly Sanofi-Genzyme)

Dr. Harshal Kubavat
Head, Strategic Consulting, Life Sciences, INOVIS
(formerly Brand Manager, Roche)

DEVELOPING YOUR COMPETITIVE EXPERTISE:
Late Life-Cycle Management & Competitive Uncertainty

Tuesday, September 17, 9:30 to 11:45 AM

This workshop session (with breakouts), will give participants first-hand insights from combined 30+ years of experience dealing with uncertainty and helping Big Pharma optimize their late-life cycle strategies — i.e. enabling companies to protect and optimize their assets.

PART-A: Threat-Analysis as a Strategy to Manage Uncertainty

Using an INOVIS proprietary strategy-gaming exercise, participants will be provided with a business case study and suggested frameworks to perform threat analysis, in order to:

• Apply new analytical frameworks to a pharma-like business case study in a learning environment
• Evaluate the importance of comprehensive and robust threat assessments and the impact these can have on strategic decision making (commercial readiness, development programs, BD opportunities, forecasting, scenario planning, mitigation plans, etc.)
• Acquire ideas and initiatives that can be rapidly integrated into ongoing CI Practice

PART-B: Gx/Biosimilar CI Assessments and Strategic Framework

Leveraging a specific Gx / biosimilar example, the second part of this workshop will address and highlight best practices when implementing follow-up activities related to identified actions during a strategic gaming exercise, this interactive workshop session will specifically enable you to:

• Get to the core issues at hand and the appropriate CI solution
• Identify appropriate analytical activities
• Set up a best-in-industry Gx/biosimilar RI and CI tracking program
• Understand Gx / Biosimilar product development and entry strategies
• Identify potential actions to optimize launches

FOR MORE INFO please contact Baljit Singh > baljit@inovis.global

COMPETITIVE INTELLIGENCE "PRIME":
Can Our Industry Keep Up?

Thursday, September 19, 2:50 to 3:30 PM

By exploring the rapid evolutions taking place inside and outside of the pharmaceutical industry, we will consider whether our profession has adapted at a similar pace and what more can be done to elevate our role.

With seemingly endless "on-demand", "tailored", "agile" and "VUCA-driven" solutions touching our professional and personal lives every day, this session seeks to address what best practices, ideas and solutions can be leveraged into our working practices to generate further impact to our teams, stakeholders and wider organizations. Delivered by two leading CI industry experts, the INOVIS team looks forward to an engaging, dynamic and hopefully provocative audience participation-driven approach, which will leave you with a fresh outlook on the future of CI in the Pharmaceutical industry and how to optimize your personal impact on decision making!

FOR MORE INFO please contact Baljit Singh > baljit@inovis.global